Applied Therapeutics (NASDAQ: APLT)

Some price data may be temporarily unavailable.

KEY DATA POINTS

Current Price

N/A

Daily Change

N/A

Day's Range

N/A

Previous Close

N/A

Open

N/A

Beta

N/A

Volume

N/A

Average Volume

N/A

Sector

Health Care

Market Cap

N/A

Market Cap / Employee

N/A

52wk Range

N/A

Revenue

N/A

Gross Margin

N/A

Dividend Yield

N/A

EPS

N/A

CAPs Rating

N/A

Industry

Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Applied Therapeutics Company Info

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.